Andere Kunden interessierten sich auch für
![The Bacteria Causing Vaginosis]( "The Bacteria Causing Vaginosis")
The Bacteria Causing Vaginosis45,99 €![A Breast Cancer Journey: Living It One Step at a Time]( "A Breast Cancer Journey: Living It One Step at a Time")
A Breast Cancer Journey: Living It One Step at a Time18,99 €![Diagnosis Cancer!]( "Diagnosis Cancer!")
Diagnosis Cancer!15,99 €![Lifechanger: How to Starve Cancer Using Metabolic Strategies & Deep Therapeutic Ketosis]( "Lifechanger: How to Starve Cancer Using Metabolic Strategies & Deep Therapeutic Ketosis")
Lifechanger: How to Starve Cancer Using Metabolic Strategies & Deep Therapeutic Ketosis17,99 €![Prostate Cancer]( "Prostate Cancer")
Prostate Cancer18,99 €![A Year Lost, a Life Gained: Fighting Breast Cancer with Wit, Humor, Friends and a Perky Poodle Volume 1]( "A Year Lost, a Life Gained: Fighting Breast Cancer with Wit, Humor, Friends and a Perky Poodle Volume 1")
A Year Lost, a Life Gained: Fighting Breast Cancer with Wit, Humor, Friends and a Perky Poodle Volume 113,99 €![Tuberculosis - India is fighting for elimination: Weaker private sector in managing TB: Drug Resistant TB - a big challenge]( "Tuberculosis - India is fighting for elimination: Weaker private sector in managing TB: Drug Resistant TB - a big challenge")
Tuberculosis - India is fighting for elimination: Weaker private sector in managing TB: Drug Resistant TB - a big challenge36,99 €
This book dives into the financial side of cancer treatment, focusing on immunotherapy. It analyzes costs of new treatments, comparing them to traditional methods.Chapter 1 gives an economic overview of cancer immunotherapy, including cost analyses, funding, and global impact. Chapter 2 explores checkpoint inhibitor pricing and financial aid models. Chapter 3 breaks down CAR T-cell therapy expenses, while Chapter 4 examines cancer vaccine development costs.Chapters 5-11 cover various immunotherapies, discussing development costs, market adoption, and financial policies. Chapter 12 proposes strategies to lower costs and improve global access.Essential reading for healthcare financiers, policymakers, and those involved in cancer treatment, this book provides key insights into the financial implications of advanced cancer therapies.